Phase II Study to Investigate the Benefits of an Improved Deferasirox Formulation (Film-coated Tablet)
Completed · Phase 2
Conditions studied: Chronic Iron Overload Due to Transfusion-dependant Anemias
In brief
Assessed the new film-coated tablet formulation to the currently approved dispersible tablet formulation with regards to overall safety, Gastrointestinal (GI) tolerability, palatability, satisfaction and compliance
Key facts
- Study ID
- NCT02125877
- Run by
- Novartis Pharmaceuticals
- People needed
- 173
- Starts
- 2014-07-08
- Expected to finish
- 2016-02-24
- Last updated by the study team
- 2017-07-25
Who can join
Age: 10 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Lurie Children's Hospital of Chicago Onc Dept — Chicago, Illinois, United States
- Children's Hospital Boston Department of Hematology — Boston, Massachusetts, United States
- Weill Cornell Medical College-Cornell University Onc Dept — New York, New York, United States
- Children's Hospital of Philadelphia Onc. Dept — Philadelphia, Pennsylvania, United States
- Novartis Investigative Site — Buenos Aires, Argentina
- Novartis Investigative Site — Linz, Austria
- Novartis Investigative Site — Vienna, Austria
- Novartis Investigative Site — Lille, France
- Novartis Investigative Site — Paris, France
- Novartis Investigative Site — Mannheim, Baden-Wurttemberg, Germany
- Novartis Investigative Site — Berlin, Germany
- Novartis Investigative Site — Dresden, Germany
- Novartis Investigative Site — Goslar, Germany
- Novartis Investigative Site — Hanover, Germany
- Novartis Investigative Site — Leipzig, Germany
- Novartis Investigative Site — Potsdam, Germany
- Novartis Investigative Site — Athens, GR, Greece
- Novartis Investigative Site — Patra - RIO, GR, Greece
- Novartis Investigative Site — Thessaloniki, GR, Greece
- Novartis Investigative Site — Brindisi, BR, Italy
- Novartis Investigative Site — Catania, CT, Italy
- Novartis Investigative Site — Cona, FE, Italy
- Novartis Investigative Site — Genova, GE, Italy
- Novartis Investigative Site — Genova, GE, Italy
- Children's Hospital of Orange County Onc Dept — Orange, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.